Scale of differentiated service delivery implementation in HIV care facilities in low- and middle-income countries: a global facility survey.

dc.contributor.affiliationInstituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
dc.contributor.affiliationNational Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
dc.contributor.affiliationDepartment of Clinical Research, University of Bern, Bern, Switzerland.
dc.contributor.affiliationSchool of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya.
dc.contributor.affiliationKheth'Impilo AIDS Free Living, Cape Town, South Africa.
dc.contributor.affiliationLighthouse Trust, Lilongwe, Malawi.
dc.contributor.affiliationUniversidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
dc.contributor.affiliationUniversity of Buea, Buea, Cameroon.
dc.contributor.affiliationSolidarMed, Pemba, Mozambique.
dc.contributor.affiliationInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
dc.contributor.affiliationDepartment of Pediatrics, Hospital Likas, Kota Kinabalu, Malaysia.
dc.contributor.affiliationDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center (VUMC), Nashville, Tennessee, USA.
dc.contributor.affiliationLome University, Lome, Togo.
dc.contributor.affiliationDepartment of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland.
dc.contributor.affiliationCentre National de Référence en matière de VIH/SIDA (CNR), Bujumbura, Burundi.
dc.contributor.affiliationDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
dc.contributor.affiliationInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
dc.contributor.affiliationUniversity of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France.
dc.contributor.affiliationEinstein-Rwanda Research and Capacity Building Program, Research for Development and Rwanda Military Referral and Teaching Hospital, Kigali, Rwanda.
dc.contributor.affiliationMorogoro Regional Hospital - CTC, Indiana University, Morogoro, Tanzania.
dc.contributor.affiliationThe Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
dc.contributor.affiliationDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.
dc.contributor.affiliationCentre national de référence pour la recherche et la prise en charge des PVVIH au Centre National Hospitalier Universitaire HK MAGA (CNHU-HKM), Cotonou, Bénin.
dc.contributor.affiliationDivision of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
dc.contributor.affiliationFaculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
dc.contributor.affiliationUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.
dc.contributor.affiliationCentre de Traitement Ambulatoire of Brazzaville, Brazzaville, Congo.
dc.contributor.authorFernández Villalobos NV
dc.contributor.authorHelfenstein F
dc.contributor.authorKhol V
dc.contributor.authorTwizere C
dc.contributor.authorSecco M
dc.contributor.authorCastelnuovo B
dc.contributor.authorHuwa J
dc.contributor.authorTiendredbeogo T
dc.contributor.authorWester CW
dc.contributor.authorFong SM
dc.contributor.authorMurenzi G
dc.contributor.authorCaro-Vega Y
dc.contributor.authorLyamuya RE
dc.contributor.authorRafael I
dc.contributor.authorZannou DM
dc.contributor.authorPetoumenos K
dc.contributor.authorNsonde DM
dc.contributor.authorPinto J
dc.contributor.authorWools-Kaloustian K
dc.contributor.authorMoore CB
dc.contributor.authorTakassi OE
dc.contributor.authorKiertiburanakul S
dc.contributor.authorAwoh RA
dc.contributor.authorAli SM
dc.contributor.authorFatti G
dc.contributor.authorMalateste K
dc.contributor.authorZaniewski E
dc.contributor.authorBallif M
dc.date.accessioned2025-07-10T11:06:25Z
dc.date.issued2025-Jul
dc.description.abstractINTRODUCTION: In 2016, the World Health Organization recommended differentiated service delivery (DSD) as a client-centred approach to simplify HIV care in frequency and intensity, thus reducing the clinic visit burden on individuals and HIV programmes. We describe the scale of DSD implementation among HIV facilities in low- and middle-income countries (LMICs) in Latin America, Africa and the Asia-Pacific before the COVID-19 pandemic. METHODS: We analysed facility-level survey data from HIV care facilities participating in the International epidemiology Databases to Evaluate AIDS consortium in 2019. We used descriptive statistics to summarise the availability of DSD, multi-month dispensing (MMD) and DSD for HIV treatment models. We explored factors associated with DSD implementation using multivariable models. RESULTS: We included 175 facilities in the Asia-Pacific (n = 30), Latin America (n = 8), Central Africa (n = 21), East Africa (n = 74), Southern Africa (n = 28) and West Africa (n = 14). Overall, 133 facilities (76%) reported implementing DSD. Of these, 91% offered DSD for HIV treatment, 61% for HIV testing and 59% for antiretroviral therapy (ART) initiation. The most common duration of ART refills for clinically stable clients was 3MMD, (70%), followed by monthly (14%) and 6MMD (10%). Facility-based individual models were the most frequently available DSD for the HIV treatment model (82%), followed by client-managed group models (60%). Out-of-facility individual models were available at 48% of facilities. Facility-based individual models were particularly common among facilities in East (92%) and Southern Africa (96%). Facilities in medium and high HIV prevalence countries, and those with 3MMD, were more likely to implement DSD. CONCLUSIONS: In 2019, DSD was available in most HIV care facilities globally but was not evenly implemented across regions and HIV services. Most offered facility-based DSD for HIV treatment models and 3MMD for clinically stable clients. Efforts to expand DSD for HIV testing and ART initiation and to offer longer MMD can improve long-term retention in care of people living with HIV in LMICs, while further alleviating the operational burden on healthcare services. These findings from the pre-COVID-19 era underline the need for strengthening DSD in HIV care, which remains at the centre of current efforts towards client-centred care.
dc.identifier.doi10.1002/jia2.26477
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10818
dc.identifier.uri.pubmedhttps://pubmed.ncbi.nlm.nih.gov/40622380/
dc.sourceJournal of the International AIDS Society
dc.titleScale of differentiated service delivery implementation in HIV care facilities in low- and middle-income countries: a global facility survey.

Files

Collections